Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsManagement of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapyInfluence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusPopulation ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the curesRole of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentApplication of marginal structural models in pharmacoepidemiologic studies: a systematic review.Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureAntiretroviral therapy: current drugsGene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysisCystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review.Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis.Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy.Proteinuria is common among HIV patients: what are we missing?Markers of renal disease and function are associated with systemic inflammation in HIV infection.Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.Thirty-day hospital readmissions for adults with and without HIV infection.Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veteransFrequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.Kidney disease in children and adolescents with perinatal HIV-1 infection.Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.Thirty-day hospital readmission rate among adults living with HIVIncidence of stage 3 chronic kidney disease and progression on tenofovir-based regimensHIV infection with viro-immunological dissociation in a patient with polycystic kidney disease: Candidate for transplantation?Serious Non-AIDS events: Immunopathogenesis and interventional strategies.Plasma apolipoprotein L1 levels do not correlate with CKD.Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.Organ Transplantation and HIV Progress or Success? A Review of Current Status.Risk of coronary heart disease in patients with HIV infection.APOL1 nephropathy: from gene to mechanisms of kidney injury.Monitoring of kidney function in HIV-positive patients.Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.Chronic kidney disease in Australian HIV-infected patients: analysis of the Australian HIV Observational Database.
P2860
Q26740117-C96713E8-B11F-451A-B109-563C20EC2ABAQ26775832-662F1117-5333-4CC3-B5C8-E72EFBDEE57FQ26851535-AEAF8775-7663-4FF6-A718-29BEE113150DQ28391758-FF5B49F0-9946-4CD8-BF82-768753628169Q28533843-984DE53C-3ACD-4E3D-B8D5-2905EBA6824CQ28554081-33CB2ECA-D257-4F47-A166-179E41035C7CQ33707284-7A7B251F-CB59-461F-A4C8-F0D4A2052D46Q33880241-41779183-E95D-47D8-9E35-FD91B0641957Q34085926-28B791FF-AF21-494E-B382-DC2ABB66FCFAQ34455119-39990597-9F64-4C6E-9647-C7B397A6E7FDQ34736194-B2593628-D868-457E-8849-563D05ACF8FAQ35036409-C6FD4187-6D4C-41AB-8FF7-4BECFA63B2B8Q35071954-9ADC2EB3-D84C-40E2-BC3D-AABB59376CC3Q35186842-130A61CE-E414-468E-B4C9-E777A0037548Q35630635-819A03E0-C6AC-41CC-8B7B-4D02C3675CE8Q35682519-C4FD8E74-8D9A-42C4-8058-62B25D180C44Q35758954-D196C0A3-CC0F-4FFF-BCD7-B83EEB01FEF6Q36150549-93FE82A3-CD58-4772-BF68-5A5C53262971Q36206108-B1DFED1D-481D-4A0E-8735-3AF39DF2B391Q36349456-62EDFBFB-2E55-4DDC-B4A0-DF3D832A2968Q36464062-64EEAA19-4F22-4EAB-9CBB-1A0A4153E102Q36746411-5627606D-446E-4CD3-AC48-0C462B17BA44Q36903905-C82BCFCE-5CD6-433C-ABE1-6A9F0D7C8F77Q36942310-36713C03-C7AB-4899-8EDF-4CB2DE8E4F3CQ36988748-505C2C0B-6882-4A5F-97B1-F0B487145383Q37122279-81CBB669-FD22-4B38-8BB5-381784028608Q37187535-D3476E98-3507-428A-8DB2-C207E944FC71Q37228619-76422C31-539B-44C3-9354-D06B9BE1E0F5Q37263602-E68E087C-F04F-458B-AD40-49F0730FA88CQ37342892-89B8938A-E9B4-4D41-9E95-655C3DAF9785Q37418140-27CD1663-4477-437E-9D1F-9AE68F4F001FQ37604753-8AB5EDD0-C656-4AD5-99B2-6E91A690B384Q37686155-00447CC1-FF8E-4966-9350-8EE4C1554D2AQ37713060-F4A6F763-1B62-460F-946D-82C5C1319500Q38067660-AF44FEB5-CBA9-48CC-B560-BE157A32C85AQ38261508-E09EB3F1-447A-43C2-8756-9C69532EBA2BQ38308481-C1F2A7E2-C251-422C-8572-5051F1DBAB8AQ38461294-9449F7AE-CFA4-419C-9EE4-6780C66FE97CQ38566131-2D742D29-31E2-4C4F-8D2F-C54C4A1C7EB6Q38681101-3136C9AE-04C8-4F53-8174-9AB03A64EEFC
P2860
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Risk factors for chronic kidne ...... viral therapy in routine care.
@ast
Risk factors for chronic kidne ...... viral therapy in routine care.
@en
type
label
Risk factors for chronic kidne ...... viral therapy in routine care.
@ast
Risk factors for chronic kidne ...... viral therapy in routine care.
@en
prefLabel
Risk factors for chronic kidne ...... viral therapy in routine care.
@ast
Risk factors for chronic kidne ...... viral therapy in routine care.
@en
P2093
P2860
P1433
P1476
Risk factors for chronic kidne ...... viral therapy in routine care.
@en
P2093
Heidi M Crane
James H Willig
Jeffrey N Martin
Mari M Kitahata
Rhoderick N Mechekano
Richard D Moore
Robert A Salata
Robert C Kalayjian
Zipporah Krishnasami
P2860
P304
P356
10.1097/QAD.0B013E328357F5ED
P407
P577
2012-09-01T00:00:00Z